World's Best Scientists 2026 revealed!
Mark Crowther

Mark Crowther

Award Badge
Medicine
Canada
2023

D-Index & Metrics

Medicine

D-Index
136
Citations
86154
World Ranking
1949
National Ranking
72

Mark Crowther publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark Crowther sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 840 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark Crowther D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark Crowther sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 136 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Canada Leader Award
  • 2017 - Fellow of the Royal Society of Canada Academy of Science

Overview

Mark Crowther is affiliated with McMaster University in Canada and has contributed extensively to medical research, particularly within the field of Medicine. Their work spans multiple subfields including Cardiology and Cardiovascular Medicine, Hematology, Internal Medicine, Surgery, and Genetics. The focus of their research has covered a wide range of topics, prominently featuring Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, Systemic Lupus Erythematosus Research, Heparin-Induced Thrombocytopenia and Thrombosis, Platelet Disorders and Treatments, Blood Coagulation and Thrombosis Mechanisms, and Cardiac Arrhythmias and Treatments.

Crowther has published papers in various high-impact venues. Frequent publication outlets include Blood, Research and Practice in Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Thrombosis Research, and Blood Advances.

Their notable recent papers include:

  • Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update, 2021, Critical Care Medicine
  • 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, 2023, Annals of the Rheumatic Diseases
  • The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, 2023, Arthritis & Rheumatology
  • GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy, 2020, Journal of Clinical Epidemiology
  • Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage, 2024, New England Journal of Medicine

Crowther has collaborated frequently with several co-authors, including Allen Li and Ali Eshaghpour, each with 27 collaborations, John W. Eikelboom with 14, David García with 12, and Siraj Mithoowani with 11 collaborations. This network illustrates a consistent engagement in collaborative research across various specialized topics.

The scientist has received recognition as a Fellow of the Royal Society of Canada in 2017, acknowledged within the Academy of Science category.

Best Publications

  • Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

    Clive Kearon;Elie A. Akl;Anthony J. Comerota;Paolo Prandoni

  • Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    Jack Ansell;Jack Hirsh;Elaine Hylek;Alan Jacobson

  • The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

    Cindy Neunert;Wendy Lim;Mark Crowther;Alan Cohen

  • Executive Summary : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

    Gordon H. Guyatt;Elie A. Akl;Elie A. Akl;Mark Crowther;David D. Gutterman

  • Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

    Walter Ageno;Alexander S Gallus;Ann K Wittkowsky;Mark Crowther

  • Evidence-Based Management of Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

    Anne Holbrook;Sam Schulman;Daniel M. Witt;Per Olav Vandvik

  • Systematic overview of warfarin and its drug and food interactions.

    Anne M. Holbrook;Jennifer A. Pereira;Renee Labiris;Heather McDonald

  • Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

    Lori-Ann Linkins;Antonio L. Dans;Lisa K. Moores;Robert Bona

  • Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

    Abstr Act;Deborah M. Siegal;John T. Curnutte;Stuart J. Connolly

  • Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

    Clive Kearon;Jeffrey S. Ginsberg;Michael J. Kovacs;David R. Anderson

  • A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome

    Mark A. Crowther;Jeff S. Ginsberg;Jim Julian;Judah Denburg

  • Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

    Shannon M. Bates;Roman Jaeschke;Scott M. Stevens;Steven Goodacre

  • Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes

    Fernando Botto;Pablo Alonso-Coello;Matthew T V Chan;Matthew T V Chan;Juan Carlos Villar

  • Acute Kidney Injury After Cardiac Surgery Focus on Modifiable Risk Factors

    Keyvan Karkouti;Duminda N. Wijeysundera;Terrence M. Yau;Jeannie L. Callum

  • Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

    Stuart J. Connolly;Truman J. Milling;John W. Eikelboom;C. Michael Gibson

  • Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

    Stuart J. Connolly;Mark Crowther;John W. Eikelboom;C. Michael Gibson

  • Systematic review : Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura

    Donald M. Arnold;Francesco Dentali;Mark A. Crowther;Ralph M. Meyer

  • Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.

    Christine H. Lee;Christine H. Lee;Theodore Steiner;Elaine O. Petrof;Marek Smieja;Marek Smieja

  • Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.

    Francesco Dentali;James D. Douketis;Monica Gianni;Wendy Lim

  • Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

    Marc A. Rodger;Susan R. Kahn;Philip S. Wells;David A. Anderson

Frequent Co-Authors

James D. Douketis
James D. Douketis McMaster University
Deborah J. Cook
Deborah J. Cook McMaster University
Jeffrey S. Ginsberg
Jeffrey S. Ginsberg McMaster University
Gordon H. Guyatt
Gordon H. Guyatt McMaster University
John W. Eikelboom
John W. Eikelboom Population Health Research Institute
Susan R. Kahn
Susan R. Kahn McGill University
Theodore E. Warkentin
Theodore E. Warkentin McMaster University
Walter Ageno
Walter Ageno University of Insubria
Marc A. Rodger
Marc A. Rodger Ottawa Hospital
Clive Kearon
Clive Kearon McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a healthcare career but not ready to commit to studying Medicine in the USA, there are alternative degree paths available online. Flexible online programs make it easier to enter the healthcare field, even for those with non-traditional backgrounds.

For example, direct entry msn programs for non-nurses online provide a fast-track option for those with a bachelor’s degree in another field who want to transition into nursing at the graduate level. Similarly, online adn programs for non nurses allow students to earn an associate degree in nursing, serving as a stepping stone into RN roles.

If you prefer administrative healthcare roles, exploring financial aid for medical billing and coding online classes can help you start a rewarding career in medical billing or coding with less upfront cost. Additionally, those concerned about entrance exams may find nursing schools that don't require teas test offer a more accessible application process.

These online pathways present flexible and affordable opportunities for students who want to quickly enter healthcare fields and grow their careers.

Best Scientists Citing Mark Crowther

Trending Scientists

Recently Published Articles